StoneS, GirlingJC. Deranged liver function tests in pregnancy: the importance of postnatal follow-up. Obstet Med2009;2:32–3. doi: 10.1258/om.2008.080036
2.
DuffyMJ. CA 19-9 as a marker for gastrointestinal cancers: a review. Ann Clin Biochem1998;35:364–70
3.
HedstromJ, HaglundC, HaapiainenR, StenmanUH. Serum trypsinogen-2 and trypsin-2-alpha(1)-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomas. Int J Cancer1996;66:326–31
4.
GoresGJ. Early detection and treatment of cholangiocarcinoma. Liver Transplant2000;6:S30–4
5.
BobergKM, SchrumpFE. Diagnosis and treatment of cholangiocarcinoma. Curr Gastroenterol Rep2004;6:52–9
6.
Baskin-BeyES, Moreno LunaLE, GoresGJ. Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology. J Hepatol2006;45:476–9
